A nationwide recall has been issued for a wellness supplement following the discovery of sildenafil, the active ingredient in the prescription drug Viagra. The presence of this undeclared pharmaceutical poses severe health risks, particularly through potentially fatal interactions with common heart medications.
A widespread recall has been issued for a wellness supplement after laboratory testing confirmed the presence of sildenafil, the active pharmaceutical ingredient in Viagra. The discovery highlights critical gaps in the regulation of over-the-counter 'natural' products and poses severe risks to consumers with underlying cardiovascular conditions.
About Sildenafil coverage
This page surfaces every story mentioning Sildenafil across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
What you see
What it tells you
Story count
Number of distinct stories where Sildenafil was a primary or referenced actor.
Recency clustering
Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distribution
Aggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche links
When the same entity surfaces in our sibling networks, we link to those views to enrich context.